DrugSep 24, 2025
Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug recall — FDA D-0651-2025
cGMP deviations: Temperature excursion during transportation.
Class IIFDA: OngoingSandoz Inc
Recall history in this database
Classification mix: Class I: 2, Class II: 1.
DrugJul 9, 2025
Cefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use recall — FDA D-0569-2025
Labeling: Label Mix-Up; cartons of Cefazolin for Injection, USP 1 gram were found to contain vials labeled as penicillin G potassium for Injection, USP, 20 million Unit. The vials contained…
Class IFDA: OngoingSandoz Inc
DrugJul 9, 2025
PENICILLIN G POTASSIUM Buffered Penicillin G Potassium for Injection, USP 20,000,000 Units recall — FDA D-0570-2025
Labeling: Label Mix-Up; Some vials of Cefazolin for Injection, USP 1 gram were incorrectly labeled as penicillin G potassium for Injection, USP, 20 million Unit
Class IFDA: OngoingSandoz Inc
Understanding this recall history
This page summarizes recall records in which the official source identifies Sandoz Inc as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.